About us Pricing ContactSubscribe

M

Michael Weller

University Hospital of ZurichORCID https://orcid.org/0000-0002-1748-174X

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

New England Journal of Medicine200521,276 citations

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology20097,709 citations

<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma

New England Journal of Medicine20057,163 citations

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas

Acta Neuropathologica20091,148 citations

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Acta Neuropathologica2018891 citations

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

Acta Neuropathologica2010840 citations

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Acta Neuropathologica2020515 citations

Novel, improved grading system(s) for IDH-mutant astrocytic gliomas

Acta Neuropathologica2018463 citations

Michael Weller · Scinovex